Inflammatory bowel disease and seronegative spondyloarthriti: two sides of the same coin?
E.N. BELOUSOVA2, A.Kh. ODINTSOVA1, A.Kh. RAMAZANOVA1,2, L.R. SADYKOVA1
1Kazan State Medical University, 49 Butlerov St., Kazan, Russian Federation, 420012
2Republican Clinical Hospital of the MH of RT, 138 Orenburgskiy Trakt, Kazan, Russian Federation, 420064
Belousova E.N. — doctor-ordinator of the Department of Hospital Therapy, tel. +7-906-320-47-72, e-mail: vanilla16@mail.ru
Odintsova A.Kh. — Cand. Med. Sc., Head of the gastroenterology department, tel. +7-987-290-53-44, e-mail: odincovaa@yandex.ru
Ramazanova A.Kh. — doctor of the gastroenterology department, postgraduate student of the Department of Biochemistry, tel. +7-927-404-74-40, e-mail: alsuramazan@mail.ru
Sadykova L.R. — doctor of the gastroenterology department, tel. +7-987-417-89-57, e-mail: s.leila87@icloud.com
Inflammatory bowel disease (IBD) is associated with a variety of extraintestinal manifestations. The most common of them are the involvement of skin, joints and oral, ocular manifestations. Extraintestinal manifestations can occur simultaneously with diarrhea, can precede symptoms of IBD or appear in the remission. Joint involvement includes arthritis, sacroiliitis and ankylosing spondylitis. Ankylosing spondylitis can develop long before the symptoms of IBD, can be the cause of severe pain and can delay the diagnosis of IBD. The paper describes a case of 23-year-old patient with the intermittent syndromes of diarrhea and joint involvement.
Key words: Inflammatory bowel disease (IBD), Crohn’s disease, extraintestinal manifestations, spondyloarthritis.
REFERENCES
- Nasonov E.L. Progress of Rheumatology at the beginning of the XXI century. Lecture. Sovremennaya revmatologiya, 2014, no. 3 (in Russ.).
- Bodryagina E.S., Abdulganieva D.I., Odintsova A.Kh. Clinical and epidemiological indicators of inflammatory bowel disease in the Republic of Tatarstan. Lechashchiy vrach, 2013, no. 7, pp. 21-26 (in Russ.).
- Rudwaleit M., Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol, 2006, vol. 20, rr. 451-71.
- Palm O., Moum B., Ongre A., Gran J.T. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J Rheumatol, 2002, vol. 29, rr. 511-5.
- Scarpa R., del Puente A. et al. The arthritis of ulcerative colitis: clinical and genetic aspects. J Rheumatol, 1992, vol. 19, rr. 373-7.
- Dekker-Saeys B.J., Meuwissen S.G. et al. Ankylosing spondylitis and inflammatory bowel disease. III. Clinical characteristics and results of histocompatibility typing (HLA B27) in 50 patients with both ankylosing spondylitis and IBD.Ann Rheum Dis, 1978, vol. 37, rr. 36-41.
- Olivieri I., Cantini F. et al. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. Autoimmunity Reviews (2014).
- Khalid A. et al. Development, Sensibility, and Reliability of the Toronto Axial Spondyloarthritis Questionnaire in Inflammatory Bowel Disease. The Journal of Reumatology, 2013, vol. 40, rr. 1726-1735.


